Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Poor-risk Subgroup of High Unmet Need - SPOC

Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, registered nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, allied health personnel, and others who are interested in care for patients and survivors in North Carolina.

Learning Objectives

  • Recall the different World Health Organization Subtypes of AML
  • Describe the diagnostic criteria of AML-MRC
  • List prognosis, treatment options, and emerging therapies for AML-MRC

 

Taking the Course

To continue, click the button Take Course.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at unclcn@unc.edu or (919) 445–1000.

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
Course opens: 
01/23/2023
Course expires: 
01/22/2024
Rating: 
0
image 

Joshua F. Zeidner, MD

Assistant Professor
Clinical Research
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

The speaker receives consulting fees from AbbVie, Bristol Myers Squibb, Daiichi Sankyo, Genentech, Gilead, Immunogen, Servier, and Shattuck Labs, and research funding from Abbvie, Arog, Astex, Gilead, Merck, Stemline, Syndax, and Takeda.  These financial relationships have been mitigated through slide review by UNC CPD.

 

To receive free Continuing Education Credit for this Self-Paced, Online Course:

  • Watch the video
  • Complete the assessment with a score of 80% or better
  • Complete the evaluation
  • Download the appropriate certificate

The following accrediting agencies have approved this course for continuing education credits. Participants should understand that their individual participation and claiming credit must abide by the regulations set forth by their respective accrediting agency.

1.00 NCPD/CNE
The University of North Carolina at Chapel Hill is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

1.00 ACPE Pharmacist
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
**No partial credit will be available**

1.00 ACPE Pharmacy Tech
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
**No partial credit will be available**

1.00 CTR
Approved by the National Cancer Registrars Association (NCRA).

1.00 ASRT
Approved by the American Society of Radiologic Technologists (ASRT).


In most cases, regulations prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to view a minimum of 50 minutes of the live webinar video to receive CE credit. Please contact your individual accreditation agencies for more details.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
Please login or register to take this course.